Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer

Targeted therapies have dramatically changed the treatment paradigm for a select group of patients with non-small cell lung cancer (NSCLC) whose tumors harbor targetable genetic aberrations. Patients with such genetic changes enjoy excellent responses to tyrosine kinase inhibitors (TKIs), but resist...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Transl Med
Egile Nagusiak: Marmarelis, Melina, Thompson, Jeffrey C., Aggarwal, Charu, Evans, Tracey L., Carpenter, Erica, Cohen, Roger B., Langer, Corey J., Bauml, Joshua
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2017
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635259/
https://ncbi.nlm.nih.gov/pubmed/29057240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.07.29
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak